2024年12月29日 11:50中关村在线 ...

TRN-157 is under clinical development by Theron Pharmaceuticals and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).

Technical analysis for Trinity Industries Inc. TRN including support levels resistance levels and stop losses for TRN ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Principal Financial Group Inc. reduced its stake in shares of Trinity Industries, Inc. (NYSE:TRN – Free Report) by 3.9% in the 3rd quarter, according to its most recent Form 13F filing with the ...